BioCentury
ARTICLE | Company News

Eli Lilly, Cerecor deal

October 10, 2016 7:00 AM UTC

Eli Lilly granted Cerecor exclusive, worldwide rights to develop and commercialize CERC-611 (formerly LY3130418). Cerecor expects to begin Phase I testing of the transmembrane AMPAR regulatory protei...